Introduction
The cystine-glutamate exchanger, known as system x c − , mediates the Na + -independent electroneutral exchange of cystine and glutamate (Palacin et al. 1998; McBean 2002) . System x c − is a member of the glycoprotein-associated amino-acid transporter family (Verrey et al. 2000) . Transporters in this family are obligate exchangers that form heterodimers with a glycoprotein subunit, called the heavy chain, permitting functional surface expression. System x c − comprises the transporter subunit xCT, which is a 502 amino-acid-containing protein with twelve putative transmembrane domains, and the heavy chain 4F2hc (also known as CD98), which is a cell-surface glycoprotein.
Under physiological conditions, system x c − transports cystine into cells coupled to the efflux of intracellular glutamate. Once inside the cell, cystine is reduced to cysteine, which is required for the synthesis of the antioxidant glutathione (GSH), a tripeptide consisting of glutamic acid, cysteine, and glycine. Cellular synthesis of GSH is limited by intracellular levels of cysteine; thus, system x c − plays a critical role in GSH homeostasis. As GSH is necessary for the protection of cells against oxidative damage, system x c − assumes significance as a transport system closely associated with the cellular antioxidant machinery. The relevance of system x c − to cellular antioxidant processes is underscored by its upregulation in many cell types exposed to oxidative stress (Bridges et al. 2001; Sato et al. 2001; Gukasyan et al. 2003; Hosoya et al. 2002; Tomi et al. 2002; Sasaki et al. 2002) .
As reviewed by McBean (2002) , experimental evidence supports a model in which cystine is taken up, by astrocytes, for GSH formation, which is then released to supply this antioxidant to neurons. The model is based on early observations that neurons tend not to accumulate cystine; however, new evidence has emerged from studies of both hippocampal ) and cortical (Danbolt 2001) neurons, demonstrating the uptake of cystine. Thus, whereas astrocytes are clearly important in providing GSH to neurons, these recent results suggest that at least some neuronal cells in culture are able efficiently to transport cystine and maintain adequate GSH levels, even without astrocytic support Shanker et al. 2001) .
The retina is extremely vulnerable to oxidative stress, and therefore system x c − has been studied in this tissue. Kato et al. (1993) have described system x c − expression in Müller cells, the predominant glial cell of the retina. These findings have been confirmed by Pow (2001) using an antibody against aminoadipic acid, which is a selectively transported substrate for system x c − . System x c − has been studied extensively at the functional and molecular level in Müller cells (Tomi et al. 2003) and also in retinal endothelial cells Tomi et al. 2002) . In addition to these two cell types, our laboratory has characterized system x c − in retinal pigment epithelial (RPE) cells and shown that it is upregulated by exposure to nitric oxide (NO) donors (Bridges et al. 2001) and by the HIV-1 transactivator protein, Tat (Bridges et al. 2004 ). In the latter study, immunolocalization studies with affinity purified antibodies against xCT and against 4F2hc (CD98) have suggested the colocalization of these components of system x c − in several retinal cell layers, including neurons of the ganglion cell layer. We were intrigued that system x c − might be present in retinal ganglion cells. These cells are the second order neurons of the visual system and are susceptible to many types of insult, including oxidative stress (Moreno et al. 2004; Boyd et al. 2003) and die in a number of retinal diseases such as glaucoma (Levin and Gordon 2002) . Recently, we and others have reported that ganglion cells die in diabetic retinopathy (Gardner et al. 2002; Martin et al. 2004; Barber et al. 2005) . NO is a molecule implicated in the pathogenic complications of diabetic retinopathy (Goldstein et al. 1996; Schmetterer et al. 1997; Du et al. 2004; Yilmaz et al. 2000) . Yilmaz and co-workers (2000) have reported a five-fold elevation of NO in the vitreous of patients with proliferative diabetic retinopathy compared with nondiabetic control patients. The observation that NO levels are increased in diabetic retinopathy, coupled with our findings that NO can upregulate system x c − in RPE cells (Bridges et al. 2001) , has led us to ask whether this transporter is present in ganglion cells, and if so, whether it is upregulated by NO in these cells.
In the present study, we have used the retinal ganglion cell line (RGC-5) (Krishnamoorthy et al. 2001) to assess the effects of various NO donors on the activity and expression of system x c − . Since this is a transformed cell line, we have also studied primary ganglion cells isolated from neonatal and adult mouse retinas and determined that xCT and 4F2hc are present in these primary neurons. Using the RGC-5 cells, we demonstrate that exposure of cells to the NO donor, 3-nitroso-N-acetylpenicillamine (SNAP), leads to a significant increase in system x c − activity, and that exposure of these cells to SNAP upregulates the gene expression of the xCT component of system x c − . Additional experiments with various other donors of reactive oxygen species (ROS) have shown similar stimulation of system x c − in RGC-5 cells.
Materials and methods

Reagents
Reagents were obtained from the following sources: Dulbecco's modified Eagle's medium F12 (DMEM:F12) medium, Earl's balanced salt solution, Dulbecco's phosphate-buffered saline (DPBS), neurobasal medium, TRIzol reagent, and penicillin-streptomycin were from Gibco-Life Technologies (Rockville, Md.); [2,3- 3 H]-glutamate (specific radioactivity 50.0 Ci/mmol) was from Amersham Bioscience (Arlington Heights, Ill.); L- [4, H(N)]-leucine (specific radioactivity 60 Ci/mmol) was from New England Nuclear (Boston, Mass.); L-[2, H]-alanine (specific radioactivity 40 Ci/mmol) was from Moravek Biochemicals (Brea, Calif.); 4F2hc (CD98) goat polyclonal IgG, goat anti-rabbit IgG-HRP, and goat anti-mouse IgG-HRP were from Santa Cruz Biotechnology (Santa Cruz, Calif.); Cy-3-conjugated anti-rabbbit IgG, peroxidaseconjugated AffiniPure rabbit anti-goat IgG, and AlexaFluor-488-conjugated anti-goat IgG were from In Vitrogen (Carlsbad, Calif.); Hoechst dye 33342 and the Live-Dead Assay were from Molecular Probes (Eugene, Ore.); the ECL detection kit was from Pierce Biotechnology (Rockford, Ill.); Protein Assay Reagent was from BioRad (Hercules, Calif.); Power Block was from BioGenex (San Ramon, Calif.); the Glutathione Detection Kit was from Chemicon International (Temecula, Calif.); complete Mini Protease Inhibitor Cocktail tablets and the GeneAmp RNA PCR Kit were from Applied Biosystems/Roche Molecular System (Branchburg, N.J.); TaKaRa Taq was from Takara Bio (Otsu, Shiga, Japan); the sense and antisense primers for xCT and 4F2hc were from Integrated DNA Technologies (Coralville, Iowa); papain was from Worthington (Lakewood, N.J.), trypsin inhibitor was from Roche Applied Science (Mannheim, Germany); rabbit anti-macrophage antiserum was from Accurate Chemical (Westbury, N.Y.); AffiniPure donkey anti-rabbit IgG (H+L) was from Jackson ImmunoResearch (Westgrove, Pa.); purified rat anti-mouse Thy-1.2 antibody was from Pharmingen (San Diego, Calif.); brain-derived neurotropic factor (BDNF), ciliary neurotrophic factor (CNTF), and basic fibroblast growth factor (bFGF) were from PeproTech (Rocky Hill, N. J.); SNAP, S-nitrosoglutathione (SNOG), hydrogen peroxide 30% (W/W) solution, xanthine, xanthine oxidase, fetal bovine serum (FBS), monoclonal antibodies to β-actin and neurofilament 160, and all other chemicals were from Sigma-Aldrich (St. Louis, Mo.). RGC-5 cells were the kind gift of Dr. Neeraj Agarwal, Department of Anatomy and Cell Biology, University of North Texas Health Science Center, Fort Worth, Tex.
Culture of RGC-5 cells RGC-5 cells were maintained at 37°C in a humidified chamber of 5% CO 2 . They were cultured in 75 cm 2 flasks in DMEM:F12, supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. Culture medium was replaced with fresh medium every other day. Upon confluency, cultures were passaged by dissociation in 0.05% (w/v) trypsin in 0.01 M PBS.
Isolation and culture of primary mouse ganglion cells
Mouse retinal ganglion cells were isolated by the method of Barres et al. (1988) with minor modifications. Briefly, retinal tissue was dissected from 2-day-old C57BL/6 mice (breeding pairs maintained following our IACUC-approved protocol). In each experiment, 12-16 retinas were incubated for 30 min at 37°C in DPBS containing 16.5 units/ml papain, 0.2 mg/ml N-acetyl-L-cysteine, and 0.04% DNase. Tissues were triturated in DPBS containing 0.15% trypsin inhibitor, 0.15% bovine serum albumin (BSA), and rabbit anti-macrophage antiserum until the retinas were dissociated. Cells were pelleted by centrifugation (5 min, 200g) and then suspended in DPBS containing 1% trypsin inhibitor and 1% BSA. The retinal cell suspension was centrifuged (5 min, 200g), and the pellet was resuspended in panning buffer (DPBS, 0.02% BSA, 5 μg/ml insulin). Macrophages and microglial cells were removed by incubation of the cell suspension (40 min, 25°C) on a panning plate (75 ml flask) coated with AffiniPure donkey anti-rabbit IgG (H+L)). Non-adherent cells were incubated (1 h, 25°C) on a second panning plate (100-mm Petri dish) coated with affiniPure donkey anti-rat IgG (H+L) antibody and purified rat anti-mouse Thy-1.2 antibody. The panning dish was washed 4-5 times with DPBS. Adherent cells were released by incubation with 0.125% trypsin in Earl's balanced salt solution (8 min, 37°C). FBS (30%) in neurobasal medium was added to the suspension, and ganglion cells were collected by centrifugation (10 min, 200g). The pellet was resuspended in base medium (neurobasal medium containing 5 μg/ml insulin, 1 mM sodium pyruvate, 0.1 mg/ml transferrin, 60 ng/ml progesterone, 16 μg/ml putrescine, 40 ng/ml sodium selenite, 40 ng/ml triiodo-thyronine, 1 mM Lglutamine, 60 μg/ml N-acetyl cysteine, 2% B27, 50 ng/ml BDNF, 10 ng/ml CNTF, 10 ng/ml Forskolin, 10 ng/ml bFGF, 0.1 mg/ml BSA). Cells were grown on poly Dlysine and laminin-coated coverslips. Half of the medium was changed every third day. Cells were subjected to immunocytochemistry after 3 days of maintenance. The same method was used to isolate ganglion cells from adult C57BL/6 mice.
Measurement of system x c
− activity System x c − is an exchanger for glutamate/cystine, and thus either radiolabeled glutamate or cystine can be used as the substrate to study its function. Cystine can be taken up by multiple transporters, whereas the Na + -independent uptake of glutamate represents the function of system x c − exclusively (Bridges et al. 2001 ). Therefore, [ 3 H]glutamate was used as the substrate for uptake experiments.
Cells were seeded in 24-well culture plates at an initial density of 0.1×10 6 cells/well. Inhibition of uptake by various competitors (unlabeled glutamate, cystine, cysteine, arginine, alanine, leucine, methionine, and phenylalanine) was examined to verify the presence of a functional system x c − in RGC-5 cells. Additional pharmacologic experiments were carried out by using a range of concentrations [0.1 -1000 μM] of the known substrate for system x c − , viz., quisqualic acid (Chase et al. 2001) . The effects of various NO donors on system x c − function were examined by treating cells on the second day following seeding with the NO donors SNAP and SNOG at concentrations of 10, 50, 100, and 500 μM, for 6 and 18 h. Additional experiments were carried out with donors of ROS: hydrogen peroxide prepared from a 30% (W/W) solution at a final concentration of 0.0001%, and xanthine sodium salt/xanthine oxidase at 10 μM and 2 mU/ml, respectively, for 6 h. The concentrations were selected based on earlier reports of toxicity to retinal cells (Kortuem et al. 2000) . For uptake experiments, the culture medium was removed, and cells were washed twice with uptake buffer lacking Na + (25 mM HEPES/TRIS, 140 mM Nmethyl-D-glucamine chloride, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgSO 4 , and 5 mM glucose, pH 7.5). Uptake was initiated by adding 250 μl uptake buffer containing [ 3 H]glutamate. Cells were incubated for 15 min at 37°C, the medium was removed, and the cells were washed thrice with ice-cold uptake buffer. The cells were solubilized with 0.5 ml 1% sodium dodecyl sulfate-0.2 N NaOH (SDS/NaOH) and used for the determination of radioactivity by liquid scintillation spectrometry with our published method (Bridges et al. 2001 (Bridges et al. , 2004 . Saturation kinetics was analyzed by fitting the data to the MichaelisMenten equation. The Michaelis constant (K t ) was calculated by nonlinear regression analysis and confirmed by linear regression. Experiments were repeated two or three times, and results are expressed as mean±SE.
Semiquantitative reverse transcription/polymerase chain reaction analysis of xCT and 4F2hc mRNA Initial studies were performed to establish the expression of xCT mRNA in RGC-5 cells compared with expression in mouse RPE cells, a positive control for xCT (Bridges et al. 2001) . Subsequent analyses assessed xCT and 4F2hc in control cells and in cells treated with NO donors. Confluent RGC-5 cells were cultured in medium in the presence or absence of 50 μM SNAP for 6 h. Total RNA was prepared by using TRIzol. Reverse transcription/polymerase chain reaction (RT-PCR) was carried out by using primer pairs specific for xCT and 4F2hc. The primers for xCT were 5'-CCCAAGGGCATACTCCAGAC-3' (sense) and 5'-CTCCGCACTGATGGTGGTAAA-3' (antisense) corresponding to nucleotide positions 515-535 and 1184-1204, respectively, of mouse xCT cDNA (Sato et al. 1999) . The expected size of the PCR product, predicted from the positions of the primers, was 690 bp. We used the mouse nucleotide sequence to design the xCT-specific RT-PCR primers for use with RGC-5 cells. The primers for 4F2hc were 5'-ATCCAAGGAGGAGCTATTCAAG-3' (sense) and 5'-CGTCCACTCAGCCAAGTAG-3' (antisense) corresponding to nucleotide positions 367-389 and 949-971, respectively, of the rat 4F2hc cDNA. The expected size of the PCR product was 605 bp. We used 18 S RNA as the internal standard. RT-PCR was carried out for 30 cycles, with a denaturing phase of 1 min at 94°C, an annealing phase of 1 min at 60°C, and an extension of 2 min at 72°C. Aliquots of 25 μl PCR products were gel-electrophoresed and stained with ethidium bromide. For the analysis of xCT and 4F2hc expression in primary mouse ganglion cells, we used primers published by Tomi et al. (2002) , the expected PCR product sizes of which were 182 bp and 141 bp, respectively.
Preparation of antibody against xCT
No antibody is commercially available for xCT. For the generation of the antibody against xCT, we used the Antheprot Software program and determined that the peptide sequence MVRKPVVATISKGGY, which corresponds to residues 1-15 of mouse xCT protein (accession No. BAA90522), should be highly antigenic. An extra cysteine residue was added at the C-terminus of the peptide to permit conjugation with keyhole limpet hemocyanin (KLH). The peptide (2 mg) was conjugated to 2 mg of Imject maleimide activated mariculture KLH and purified by overnight dialysis. Approximately 300 μg peptideconjugated KLH in Freund's complete adjuvant was administered intradermally to New Zealand white rabbits (approximately 50 μl each). The initial injection was followed by two boosters. Antiserum was obtained 10 days after the second booster and purified by using affinity chromatography.
Western blot analysis of xCT and 4F2hc
Studies were performed to detect xCT and 4F2hc in RGC-5 and primary mouse ganglion and in RGC-5 cells treated with NO donors. For the latter experiments, RGC-5 cells were grown to confluence in DMEM:F12 medium and incubated in the presence or absence of 50 μM SNAP for 6 h. In all cases of protein preparation, the medium was discarded, and cells were washed with 0.01 M PBS (pH 7.4) and lysed with in cold lysis buffer (20 mM TRIS-HCl, pH 7.5, containing 2.5 mM EDTA, 1% Triton X-100, 1% deoxycholate sodium, 0.1% SDS, 50 mM NaF, 10 mM sodium pyrophosphate, 2 mM sodium orthovanadate, 1 mM phenylmethane sulfonyl-fluoride). Samples were sonicated for 10-15 s, and unsolubilized debris was removed by centrifugation (10 min, 10,000g, 4°C). The protein concentration in the supernatant was determined by using the BioRrad assay reagent. Equivalent amounts of protein (10 or 30 μg) from total cell lysates were boiled in Laemmli's buffer for 5 min and analyzed by 10% SDSpolyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were transferred onto nitrocellulose membranes, which were then blocked for 1.5 h at room temperature with TRIS-buffered saline/0.05% Tween-20 containing 5% non-fat milk and subsequently incubated with rabbit affinity-purified polyclonal anti-xCT antibody (1:1000) and goat polyclonal anti-4F2hc antibody (1:500) overnight at 4°C. The membranes were incubated with horseradish peroxidase-conjugated anti-rabbit and goat IgG antibody as the secondary antibody for 1.5 h and washed, and the proteins visualized by using the ECL Western blot detection system. Membranes were washed three times, blocked with 5% non-fat milk for 2 h, and reprobed with mouse monoclonal anti-β-actin antibody (1:5000). Following immunoblotting, band density was determined by using the imaging histogram feature of Adobe Photoshop CS2 (version 9.0). A drag-and-drop rectangular grid of identical size was placed on the band of interest and captured for processing. Background density was subtracted. Data represent an average of all the pixel values in the grid.
Immunocytochemical analysis of xCT and 4F2hc RGC-5 cells or primary mouse ganglion cells were cultured on coverslips. Cells were dried for 5 min, fixed in methanol for 5 min, air-dried again for 5 min, and washed three times in 0.01 M PBS (5 min). Samples were blocked with Power Block for 10 min and then incubated at room temperature for 3 h with anti-rabbit polyclonal antixCT antibody (1:500) and goat polyclonal anti-4F2hc antibody (1:100). Cells were washed three times with PBS (5 min) and incubated with Cy-3-conjugated anti-rabbit IgG for xCT and Alexa-Fluor-488-conjugated anti-goat IgG for 4F2hc. Negative control experiments were performed by blocking the anti-xCT antibody with 20 μg/ml antigenic peptide for 30 min before incubation with slides. In the case of 4F2hc, negative control experiments were performed by incubating the slides without the primary antibody. Samples were washed again with PBS and then incubated at room temperature with Hoechst dye. After being rinsed, slides were coverslipped with Vectashield mounting medium. In some cases, the Hoechst dye was omitted, and slides were coverslipped with Vectashield mounting medium containing 4,6-diamidino-2-phenylindole (DAPI) to stain nuclei. The local-ization of the two proteins was determined by epifluorescence on a Zeiss Axioplan-2 microscope equipped with an apotome (which permits optical sectioning of cells and tissues), the axiovision program, and an HRM camera. Intact eyes of mice, which had been embedded in OCT and prepared for cryosectioning, were processed for immunohistochemistry as described previously (Bridges et al. 2004; Martin et al. 2004 ).
GSH detection and assay of cell viability Cellular levels of total GSH were determined by using the Chemicon Glutathione Detection Kit. RGC-5 cells were grown in DMEM:F12 medium to confluency and incubated in the presence or absence of 50 μM SNAP for 6 h. The medium was discarded, and the cells were washed twice with cold wash buffer and incubated for 10 min with lysis buffer. Monochlorobimane (MCB) solution (supplied as part of the kit) was mixed with the cell lysate and incubated for 1 h at room temperature. The absorbance was measured by using the 360/465 filter set of a Techan Ultra spectrophotometer (Research Park Triangle, N.C.). The standard curve for GSH was established at concentrations of 1-10 μM. The protein concentration of the lysate was assayed. In additional experiments, cells were treated with SNAP (50 μM or 500 μM) for 6 h, and cell viability was measured by using the Live-Dead Assay, which uses calcein-acetoxymethyl ester (fluoresces green indicative of living cells) and ethidium homodimer-1 (fluoresces red indicative of dead cells), following the manufacturer's instructions.
Data analysis
Each uptake experiment was performed in duplicate or triplicate and was repeated 2-4 times. Data analysis (analysis of variance) was performed by using the SPSS statistical software package (P<0.05 was considered significant). For data in which variances were equivalent, the least significant difference post-hoc test was used, and for tests in which they were not equivalent, Dunnett's test was used. Kinetic analysis was performed by using Fig.P (version 6.0, Biosoft, Cambridge, UK). Data are presented as means±SE.
Results
Molecular and functional evidence for the expression of system x c − in RGC-5 cells and in primary ganglion cells isolated from mouse retina Earlier immunolocalization studies of intact retinal tissue suggested that system x c − was present in several retinal cell layers, including the ganglion cell layer (Bridges et al. 2004) . The presence of system x c − in the cultured RGC-5 Fig. 1 Expression of components of system x c − in RGC-5 cells. a RT-PCR analysis of xCT-specific mRNA transcript in mouse RPE (RPE), mouse neural retina (Retina), and the RGC-5 cell line (RGC-5). Total RNA was isolated, and RT-PCR was carried out with primers specific for mouse or rat xCT mRNA. As negative controls, the samples were subjected to RT-PCR without reverse transcriptase (-RT). DNA standards (75 bp-12.2 kb) were run on the gel in parallel to determine the size of the RT-PCR products (Marker). b Immunoblotting of membranes containing proteins isolated from RGC-5 cells (10 μg protein loaded per lane). The membranes were probed first with antibody specific for xCT (~50 kDa). Membranes were stripped and reprobed with antibody against 4F2hc (~98 kDa). c Immunodetection of the two components of system x c − , xCT and 4F2hc. xCT Protein xCT was detected by an affinity-purified anti-xCT antibody and a Cy-3-labeled secondary antibody (red). 4F2hc Protein 4F2hc was detected by anti4F2hc antibody followed by an Alexa-488-conjugated secondary antibody (green). merged The merged image obtained by using three filters to detect Cy-3, Alexa 488, and Hoescht 33342 (to stain nuclei). Areas where xCT and 4F2hc are co-localized are orange-yellow (overlap of green and red signals). The 4F2hc immunodetection shows a "shine-through" effect of the Hoechst in the merged image. Images were collected by using the Axiovision program and Zeiss Apotome technology. d Negative control of RGC-5 cells cultured in presence of the anti-xCT antibody, which had been blocked with pre-immune serum; the mounting medium contains DAPI to label cell nuclei. e RGC-5 cells cultured in the presence of anti-Thy-1 and a Cy-3 labeled secondary antibody (red). ×100 cell line had not previously been reported. To provide evidence for the expression of system x c − in RGC-5 cells, RT-PCR was used to determine whether mRNA encoding xCT, the unique component of system x c -, was present in RGC-5 cells. Our earlier experiments had demonstrated xCT expression in RPE; therefore, we used RNA from mouse RPE (Bridges et al. 2001 ) as a positive control for these studies. In the procedure for isolating mouse RPE, the neural retina was also isolated, and hence, we also examined xCT expression in this tissue.
The detection of the xCT component of system x c − in mouse RPE and neural retina and in rat RGC-5 cells, by RT-PCR, is shown in Fig. 1a . A 690-bp band was amplified in the presence of reverse transcriptase. The reaction gave no product if reverse transcriptase was not present. To establish whether the xCT and 4F2hc proteins were present in RGC-5 cells, Western blot analysis was performed. Extraction of protein from RGC-5 cells and subsequent SDS-PAGE and immunoblotting with an affinity-purified antibody against xCT detected only one band with the expected molecular weight of~50 kDa (Fig. 1b) . The same membrane was stripped and reprobed with antibody against 4F2hc and a single band of molecular weight 98 kDa was detected (Fig. 1b) . Additional evidence that the two components of system x c -, xCT and 4F2hc, colocalized was obtained by subjecting RGC-5 cells to immunocytochemical analysis with antibodies specific for these proteins (Fig. 1c) . xCT in RGC-5 cells fluoresced red (Cy-3), whereas 4F2hc fluoresced green (Alexafluor 488), as shown in Fig. 1c . Merged images (Fig. 1c) revealed that xCT co-localized with 4F2hc (fluoresced orange). However, 4F2hc had a more widespread distribution than xCT consistent with its interaction with several proteins, including xCT. Omission of the primary antibody or use of the antibody blocked with pre-immune serum resulted in no fluorescence (Fig. 1d) . The presence of Thy-1, a marker of ganglion cells was confirmed in the RGC-5 cell line (Fig. 1e) .
To obtain functional evidence for the presence of system x c − in RGC-5 cells, the uptake of glutamate into these cells was studied in Na + -free medium, and the substrate specificity of the uptake process was assessed by competition experiments. The cells took up [
3 H]glutamate in the absence of Na + . Competition experiments revealed that the Na + -independent uptake of [ 3 H]glutamate was inhibitable " Fig. 3 Detection of components of system x c − in intact mouse retina and in ganglion cells isolated from neonatal mice. a Cryosection (10 μm thick) of retina of adult mouse incubated overnight with affinity purified antibodies against Thy-1 and xCT, followed by incubation with the Cy-3 secondary antibody for Thy-1 detection and with the Alexa-488-conjugated secondary antibody for xCT detection (gcl ganglion cell layer, ipl inner plexiform layer, inl inner nuclear layer, opl outer plexiform layer, onl outer nuclear layer). The mounting medium contains DAPI for detection of nuclei (DAPI). Anti-Thy-1 labels the ganglion cells and their processes in the IPL (Thy-1). xCT labels many cells of the retina (xCT). Thy-1 and xCT co-localize as indicated by the orange fluorescence (merged image). b Differential interference contrast (DIC) image of primary ganglion cells isolated from neonatal mouse retinas grown for 3 days. The cells have long processes extending from the variably sized cell bodies, both of which are characteristics of primary ganglion cells. c DIC image of primary mouse ganglion cells immunolabeled with an antibody specific for Thy-1. d, e Immunolabeling of primary mouse ganglion cells with an antibody specific for xCT and detected with Cy-3 or for 4F2hc and detected with Cy-3, respectively. f Immunolabeling of primary mouse ganglion cell isolated from adult retina by using an antibody against xCT and detected by using Alexafluor 488 (green fluorescence). g Merged image of cells in f showing yellow-orange labeling of the cells representing colocalization of neurofilament and xCT in the adult ganglion cells. Several cells have extensive processes; others are just developing their processes after 3 days in culture. h RT-PCR analysis in primary mouse ganglion cells carried out with primers specific for mouse xCT (182 bp), 4F2hc (141 bp), and 18 S (315 bp). DNA standards (75 bp to 12.2 kbp) were run on the gel in parallel (left) to determine the size of the RT-PCR products. i Immunoblotting of xCT and 4F2hc in primary mouse ganglion cells. The cells were purified by immunopanning and immediately subjected to protein isolation, SDS-PAGE, and immunoblotting for xCT (~50 kDa) and for 4F2hc (~98 kDa). ×50 (a), ×100 (b-g) by glutamate and cystine and, to a lesser degree, by cysteine, but not by other amino acids, such as arginine, alanine, serine, leucine, methionine, or phenylalanine (Fig. 2a) . The substrate specificity of the transport system mediating the Na + -independent uptake of glutamate in these cells agreed with the known substrate specificity of system x c − . Additional pharmacologic experiments were conducted with quisqualic acid, a known substrate for system x c − (Chase et al. 2001) . In these studies, increasing concentrations of quisqualate, which had been dissolved in Na + -free uptake buffer at pH 7.5, caused a dose-dependent inhibition of the uptake of [ 3 H]glutamate. The IC 50 value (value at which 50% of the uptake of [ 3 H]glutamate was inhibited) for these studies was 3.7 μM±0.3.
Taken collectively, the data shown in Figs. 1 and 2 provide strong molecular and functional evidence that system x c − is present in RGC-5 cells. Nevertheless, when transformed cells are subjected to culture conditions, as is the case for the RGC-5 cells here, they may express proteins that do not necessarily represent the proteins expressed by the cells in vivo. An earlier report from our laboratory (Bridges et al 2004) showed positive immunodetection of xCT and 4F2hc in the ganglion cell layer (and other layers) in intact mouse retina. In the present study, we asked whether xCT co-localized with Thy-1, a ganglion cell marker, and examined cryosections of adult mouse retinas incubated with antibodies against Thy-1 and xCT and stained by DAPI. DAPI labeled the cell nuclei (Fig. 3a,  left) , whereas anti-Thy-1 labeled the ganglion cells (and their processes in the inner plexiform layer; Fig. 3a) . Immunostaining for xCT had a more widespread distribution, being detected in the ganglion cell layer and in cells of the inner and outer nuclear layers (Fig. 3a) . Merged images showed the colocalization of Thy-1 and xCT in the inner part of the retina, adding support for the expression of system x c − in the cells of the ganglion cell layer (Fig. 3a,  right) . We next used a well-established immunopanning method (Barres et al. 1988 ) and isolated ganglion cells from neonatal mouse retinas. Differential interference contrast (DIC) images (Fig. 3b) of primary ganglion cells grown for 3 days in culture medium revealed the long processes and the variously sized cell bodies characteristic of primary ganglion cells. DIC immunolabeling of the primary cells with an antibody for Thy-1 and companion immunolabeling experiments for xCT and 4F2hc established the presence of positive cells (Fig. 3c−e) . Ganglion cells immunopanned from adult mouse retina were also positive for xCT (Fig. 3f) and Thy-1 (data not shown) and for antibody against neurofilament 160 (Fig. 3g) , a marker for neurons including ganglion cells (Brzezinski et al. 2005 ). An analysis of the expression of xCT and 4F2hc in primary mouse ganglion cells by RT-PCR is shown in Fig. 3h . An additional set of primers were designed for mouse xCT and Fig. 4 Stimulation of Na + -independent uptake of glutamate in RGC-5 cells following 6-h and 18-h incubation with NO donors. Confluent RGC-5 cells were incubated at 37°C in regular DMEM:F12 medium (Con), DMEM:F12 containing 0.05% dimethylsulfoxide (DMSO), or in medium containing the NO donors at concentrations of 10, 50, 100, and 500 μM (dissolved in DMSO). a 3-Nitroso-Nacetylpenicillamine (SNAP) for 6 h. bSNAP for 18 h. c Snitrosoglutathione (SNOG) for 6 h. dSNOG for 18 h. Uptake of [ 3 H]glutamate (2.5 μM) was measured for 15 min in control and treated cells at 37°C in Na + -free medium. Values are means±SE for six determinations from two independent experiments. ***P<0.001, **P<0.01, significantly different from DMSO vehicle control. e LiveDead Assay showing an abundance of living cells (green) in cultures exposed to 0.05% DMSO-containing buffer (Control) or to 50 μM SNAP (SNAP 50 μM), and many dead (red) cells in cultures exposed to 500 μM SNAP (SNAP 500 μM). ×10 Fig. 5 Stimulation of the Na + -independent uptake of glutamate in RGC-5 cells following 6-h incubation with donors of reactive oxygen species (ROS). Confluent RGC-5 cells were incubated at 37°C for 6 h in regular DMEM:F12 medium or in medium containing the ROS donors xanthine sodium salt/xanthine oxidase [10 μM/2 mU/ml] or hydrogen peroxide [0.0001%]. Uptake of [ 3 H] glutamate (2.5 μM) was measured in these cells for 15 minutes at 37°C in Na + -free medium. Values are means±SE for three determinations from two independent experiments. ***P<0.001, significantly different from control mouse 4F2hc; a 182-bp band (xCT) and a 141-bp band (4F2hc) were amplified in the presence of reverse transcriptase. An internal 18 S standard of 315 bp was also amplified in all preparations. Immunoblotting for the detection of xCT and 4F2hc in the purified primary mouse ganglion cells isolated by immunopanning is presented in Fig. 3i . For this experiment, proteins were prepared immediately, as these cells were not cultured and thus the number of cells avaialable was small and the protein yield low. Immunoblotting detected the expected bands of~50 kDa for xCT and of~98 kDa for 4F2hc (Fig. 3i) . These data obtained from the intact mouse retinal tissue and primary ganglion cells provided strong support for the presence of system x c − in ganglion cells. Because the primary neurons do not proliferate, studies of the functional aspects of system x c − are not feasible in primary cell culture; thus the remainder of the experiments were performed with the RGC-5 cells. (Fig. 4a) . Incubations with high (500 μM) concentrations of SNAP resulted in decreased activity of system x c − , possibly reflecting toxic effects on the cells. This was confirmed by subjecting similarly treated cells to the Live-Dead Assay; many more cells died when exposed to 500 μM SNAP for 6 h than did those exposed to 50 μM SNAP or to DMSO-containing buffer (Fig. 4e) . Incubation of RGC-5 cells with SNAP at 50 μM for 18 h led to a similar stimulation of system x c − activity (Fig. 4b) . Treatment of RGC-5 cells for 6 h with the NO donor compound SNOG at concentrations of 50 and 100 μM led to~20% increase in system x c − activity (Fig. 4c) , whereas exposure of cells to SNOG at 50 μM for 18 h led to a similar stimulation of system x c − activity (Fig. 4d) as that observed for 6 h. All effects observed with the NO donors involved the use of freshly prepared solutions; incubation of cells with "spent" SNAP or SNOG showed a markedly reduced stimulatory effect (data not shown). To confirm the sensitivity of system x c − in RGC-5 cells to other forms of oxidative stress, cells were treated with donors of ROS, viz., xanthine/xanthine oxidase and hydrogen peroxide. Treatment with xanthine/xanthine oxidase, a donor of extracellular ROS, led to~45% increase in system x c − activity, whereas incubation with hydrogen peroxide stimulated the activity of the transporter in RGC-5 cells by~20% (Fig. 5) . To characterize the effects of oxidative stress on the kinetics and regulation of system x c − in RGC-5 cells, subsequent experiments involved the use of SNAP at a concentration of 50 μM for 6 h. To determine whether the increased system x c − activity induced by SNAP was a generalized effect on all transporter proteins in RGC-5 cells or whether it was specific, RGC-5 cells were incubated in the presence or absence of 50 μM SNAP, and the effect on the uptake of radiolabeled amino acids (alanine and leucine) was compared with that of glutamate. Incubation of cells with 50 μM SNAP stimulated the Na + -independent uptake of glutamate as demonstrated previously, but exposure of cells to 50 μM SNAP had no effect on the Na + -independent uptake of alanine or leucine (Fig. 6) . The uptake of these two amino acids under these conditions represents both facilitated transport and diffusion.
Kinetic analysis of system x c − in RGC-5 cells exposed to the NO donor SNAP The kinetics of system x c − activity in RGC-5 cells was analyzed in control cells and in cells treated with SNAP (Fig. 7) . The transport function of system x c − was monitored by measuring the Na + -independent uptake of glutamate. The analysis showed that the increase in the transport activity of system x c − observed in SNAP-treated RGC-5 cells compared with control cells was associated with an increase in the maximal velocity of the transporter with no significant change in substrate affinity. The maximal velocity of glutamate uptake was 1.6-fold greater in SNAPtreated cells than in control cells (16.7±0.4 vs. 11.5±0.7 nmol/ mg of protein per 15 min). The Michaelis constant for glutamate in SNAP-treated cells was similar to control cells (0.16±0.01 versus 0.16±0.03 mM).
Regulation of the expression of system x c − by NO in RGC-5 cells To determine whether system x c − expression was regulated by NO in RGCs in a manner similar to that found in RPE cells, we studied the influence of SNAP treatment on the steady-state levels of mRNA transcripts specific for 4F2hc and xCT. mRNA samples isolated from control and SNAP-treated RGC-5 cells were used for semiquantitative RT-PCR for the determination of the levels of mRNA transcripts. As an internal control, the steady-state levels of 18 S RNA were determined in the mRNA samples in parallel. Data were expressed as the ratio of the band density of the gene of interest compared to that of 18 S RNA in the same sample. The results showed that treatment with SNAP did not alter the steady-state levels of 4F2hc mRNA (Fig. 8) . In contrast, the steady-state levels of xCT mRNA increased markedly (by~50%) in SNAPtreated cells compared with that in control cells. These results suggested that the SNAP-induced increase in the transport activity of system x c − was associated with an increase in the expression of xCT with no significant change in the expression of 4F2hc.
To determine whether the levels of 4F2hc protein and xCT protein were similarly altered, proteins were extracted from RGC-5 cells incubated in the presence or absence of SNAP and used for Western analysis, with β-actin as an internal control. Immunoblotting with antibodies against 4F2hc showed no difference between the SNAP-treated cells versus control cells; however, levels of xCT protein were significantly greater in the SNAP-treated cells than in control cells (Fig. 9) .
GSH levels in RGC-5 cells treated with the NO donor SNAP Given that system x c − is an exchanger for glutamate and cystine facilitating the synthesis of the antioxidant GSH, Fig. 8 Effect of SNAP on the steady-state levels of mRNA for xCT and 4F2hc in RGC-5 cells. Confluent RGC-5 cells were incubated in the absence or presence of 50 μM SNAP for 6 h at 37°C (C control, S SNAP-treated cells). Total RNA was isolated and used for semiquantitative RT-PCR. Primer pairs specific for rat xCT mRNA (690 bp) and rat 4F2hc (605 bp) were used. 18 S RNA (315 bp) was analyzed in the same RNA samples as the internal control. RT-PCR was carried out with a wide range of PCR cycles (9-30). The resultant products were run on gels and stained with ethidium bromide. DNA standards (100 bp to 12.2 kb) were run on the gels in parallel to determine the size of the RT-PCR products. The intensity of the band was quantified as described. a Representative ethidium bromide gel (M DNA marker). b Band intensity of cDNA (4F2hc or xCT) of interest relative to 18 S cDNA band intensity in control and SNAP-treated cells. **P<0.01 coupled with the finding that the NO donor SNAP increases the activity of system x c − , we questioned whether GSH levels were altered when RGC-5 cells were treated with SNAP. Control cells, which were incubated in medium without SNAP or in 0.05% DMSO-containing medium (vehicle control), had GSH levels of 1.87±0.07 and 1.73±0.13 nmol/mg protein, respectively (Fig. 10 ). Cells treated with 50 or 100 μM SNAP had GSH levels of 2.94±0.25 and 2.98±0.17 nmol/mg protein, respectively. These data suggested that system x c − contributed to the generation of GSH, thereby providing protection during oxidative stress to RGC-5 cells.
Discussion
System x c
− has been characterized extensively in glial and RPE cells of the retina (Bridges et al. 2001 (Bridges et al. , 2004 Kato et al. 1993; Pow 2001; Tomi et al. 2003) , but not in retinal neurons. The present study has examined system x c − in retinal ganglion cells.
Earlier immunohistochemical studies from our laboratory (Bridges et al. 2004 ) had detected system x c − in the ganglion cell layer (and other cell layers) of the intact mouse retina. In the present study, we repeated these experiments to determine whether an affinity-purified antibody against xCT detected the protein in ganglion cells. Immunolabeling in intact adult mouse retina was abundant around the cell bodies of cells in the ganglion cell layer and their processes. Double-labeling experiments with antiThy-1 showed the co-localization of Thy-1 with xCT. To explore this further, we purified ganglion cells from neonatal mouse retina and performed expression analysis, immunocytochemical studies, and immunoblotting. RT-PCR analysis amplified the expected band products for xCT and 4F2hc from cells. Immunocytochemical studies detected robust levels of the xCT protein and of the 4F2hc protein. Immunoblotting confirmed the presence of these proteins in mouse ganglion cells. Additional experiments on ganglion cells isolated from adult mouse retina also positively detected xCT. Ganglion cells were isolated following the well-established methods of Barres et al. (1988) , and their identity was confirmed by using antiThy-1. The pattern of growth of the cells in culture was consistent with their identification as ganglion cells. Primary ganglion cells do not proliferate in culture, which limits their usefulness in functional studies that require a confluent population of cells.
To understand the way that system x c − functions in cells requires a method whereby sufficient numbers of cells can Fig. 10 Glutathione (GSH) levels in RGC-5 cells treated with SNAP. RGC-5 cells were incubated at 37°C for 6 h in the absence (Con) or presence of SNAP (50 μM or 100 μM) and the levels of GSH were measured as described. Some cells were treated with 0.05% DMSO-containing medium (vehicle control, DMSO). Values are means±SE for three determinations from two independent experiments. ***P<0.001, significantly different from control Fig. 9 Effect of SNAP on the levels of xCT and 4F2hc proteins in RGC-5 cells. Confluent RGC-5 cells were incubated in the absence (C) or presence (S) of 50 μM SNAP for 6 h at 37°C. Proteins were extracted from cells and subjected to SDS-PAGE, followed by immunoblotting with an affinity-purified antibody against 4F2hc (M r 90 kDa, a) or against xCT (M r 50 kDa, c) and an antibody against β-actin (M r~4 5 kDa, internal loading control, a, c). The density of the bands was quantified by densitometry: 4F2hc/β actin (b) and xCT/β-actin (d). The 4F2hc/β-actin ratio or the xCT/β-actin ratio in control cells was taken as 1. **P<0.01 be cultured and their uptake of radiolabeled substrates examined. We have used the rat ganglion cell line RGC-5 to test the function of system x c − . This cell line expresses markers of ganglion cells, but not markers for other retinal cells types, such as Müller cells, and has been described as a promising tool for studies of ganglion cell function (Krishnamoorthy et al. 2001; Boyd et al. 2003) . We used molecular, biochemical, immunohistochemical, and functional methods to establish that system x c − was present in these cells, prior to studying its regulation. RT-PCR, cloning, and sequencing data established the molecular identity of xCT mRNA in RGC-5 cells. The affinitypurified antibody prepared against a highly antigenic peptide sequence of xCT detected the protein with the appropriate molecular weight. Similarly, 4F2hc, which functions coordinately with xCT in system x c − , was detected in protein extracts of RGC-5 cells. Immunocytochemical studies co-localized the two proteins in the cultured cells. Functional studies involving the use of various unlabeled amino acids to inhibit the Na + -independent uptake of radiolabeled glutamate clearly demonstrated inhibition by the known substrates of system x c − . Additional pharmacological studies with quisqualic acid, a substrate specific for system x c − (Chase et al. 2001) , also showed increasing inhibition of glutamate uptake as levels of quisqualate were increased.
Having demonstrated the presence of system x c − in RGC-5 cells, we asked whether nitric oxide (NO) would regulate the expression and activity of the transporter in these cells, as demonstrated in RPE cells (Bridges et al. 2001) . Our data clearly showed that SNAP and SNOG, two donors of NO, increased the activity of system x c − , when exposed to the cells for 6 h. The increased activity was associated with an increase in the maximum velocity of the transporter. The molecular analysis of the two components of system x c − revealed that, within this time period, a modest increase in the expression of the mRNA encoding xCT occurred, but no change in expression of 4F2hc. Similar results were observed when the quantity of the two proteins was determined in cells treated with SNAP versus controls: the level of xCT increased, whereas the level of 4F2hc remained unchanged. Whether this modest increase in RNA and protein has any relevance for xCT regulation in in vivo retinopathy remains to be determined. The findings obtained in RGCs were similar to those reported for RPE cells (Bridges et al. 2001) . Following exposure to NO donors, the level of GSH increased in RGC-5 cells, as anticipated, since system x c − transports constituents of this antioxidant. In addition to the effects of NO donors on system x c − , we asked whether other agents, known to induce oxidative stress, such as donors of ROS and hydrogen peroxide would also stimulate the activity of system x c − ; functional assays showed that they did.
The effects of NO on system x c − are of interest because NO is thought to play a role in diabetic retinopathy. NO levels are increased in diabetes, including in patients with diabetic retinopathy (Goldstein et al. 1996; Schmetterer et al. 1997) . NO is a key factor leading to neuronal death triggered by glutamate-induced stimulation of the Nmethyl-D-aspartate (NMDA) receptor. This has been demonstrated in many neuronal cell types (Clementi 1998; Leist et al. 1997; Bonfoco et al. 1996) including retinal neurons (Leist et al. 1997; Kashii et al. 1996) . In the retina, a low concentration of NO plays a protective role in glutamate neurotoxicity by closing the NMDA receptor gated ion channel, but elevated levels of NO, interacting with oxygen radicals, become toxic and mediate glutamateinduced neurotoxicity (Kashii et al. 1996; Warr et al. 1999) .
The finding that NO stimulates the activity of system x c − raises an important question, viz., that of whether the longterm consequences of increased activity of this transporter are beneficial or could be potentially deleterious. This issue has been raised in studies of system x c − in brain slices (Warr et al. 1999) . Although a system that provides necessary constituents for the synthesis of GSH could arguably be beneficial, it must be kept in mind that, when system x c − is functioning in vivo, it exchanges glutamate for cystine. Cystine is being taken up by cells, but glutamate is being released into the extracellular milieu. Given that glutamate is toxic to ganglion cells via the stimulation of the NMDA receptor (Sucher et al. 1997) , this could be a deleterious consequence of the excess activity of system x c − . Therefore, in any retinal condition in which system x c − is upregulated, retinal Müller cells must be capable of taking up excess glutamate and converting it to glutamine. Interestingly, our data show that, whereas incubation with NO donors for 6 h or 8 h leads to increased activity of system x c − , the activity returns to baseline after 24 h exposure to NO donors, thus suggesting a self-regulating system in these cells. Compromised function of Müller cells during diabetes, including decreased activity of glutamate transporters, which has been reported by some investigators (Li and Puro 2002) , could have a major impact on whether the upregulation of system x c − in diabetes is entirely beneficial. Whether system x c − in ganglion cells isolated from an in vivo model of diabetes (such as rat or mouse) is upregulated, as our in vitro data with NO suggests, remains to be investigated.
GSH is reported to be localized primarily in Müller cells and horizontal cells in the retina, although low levels of GSH have been observed in other retinal neurons (Pow and Crook 1995) . System x c − has been detected more frequently in glial cells than other cell types (McBean 2002) , which has led to a model whereby system x c − is thought to be primarily a transporter that is active in glial cells. More recent studies that have detected system x c − in neurons Shanker et al. 2001 ) require that the model be revisited. Allen et al. (2001) point out that, although a number of experiments present data suggesting that neurons rely exclusively on GSH effluxed from astrocytes (Sagara et al. 1993a (Sagara et al. , 1993b , other studies have shown that cultured neurons (such as hippocampal neurons) readily accumulate cystine. These results agree with findings by others demonstrating that primary cultures of either cortical or hippocampal neurons accumulate 35 S-cystine (Sagara and Schubert 1998; Murphy et al. 1990 ). There is no dispute that astrocytes play a key role in providing GSH for neurons, but the transporter for cystine, system x c − , seems to be present in at least some primary neuronal cell cultures and may be functional. Our data provide strong evidence for the presence of the transporter system in primary ganglion cells of the retina. Our finding that the ganglion cell line RGC-5 upregulates this system under situations of oxidative stress similar to those that can occur in retinal disease may be relevant to diseases such as diabetic retinopathy. We have not explored the mechanism by which NO upregulates system x c − . The evidence that mRNA encoding xCT is increased in addition to the protein levels suggests that NO works at the gene level to account for at least some of the marked increase in system x c − activity. NO could act directly by nitrosylation of proteins or it could act indirectly by stimulating cGMP. Future studies should determine which mechanism(s) accounts for NO-induced system x c − activation.
